Biomagnetics Diagnostics Corporation Receives Commitment for Malaria and Tuberculosis Diagnosis Clinical Validation Testing in India Using World’s First Integrated Optical Biosensor

SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received important commitments from two leading research laboratories in India for clinical validation testing for malaria and tuberculosis (TB) detection and diagnosis.

MORE ON THIS TOPIC